Pepcid AC Chewable Tablets to Hit Store Shelves in October
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson is launching Pepcid AC chewable tablets to be available on store shelves in October following FDA's approval of the new dosage form, the company said Sept. 25. The new product contains the same active ingredient, famotidine 10 mg, as the original OTC product. J&J received the "approvable" designation for the product from FDA in December ("The Tan Sheet" Jan. 12, p. 1).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning